Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering
EMERYVILLE, Calif., April 01, 2024 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the […]
Fluent, Inc. to Announce Fourth Quarter and Full-Year 2023 Financial Results on April 2, 2024
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) — Fluent, Inc. (NASDAQ: FLNT) announced today that it will report its financial […]
Interactive Strength Inc. (Nasdaq: TRNR) Reports Fourth Quarter 2023 Results
Net Loss and Earnings per Diluted Share of $11.4 million and $0.80 Adjusted EBITDA was a $3.5 million loss, a […]
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Garden City, NY, April 01, 2024 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation […]
Zhibao Technology Inc. Announces Pricing of Initial Public Offering
Shanghai, April 01, 2024 (GLOBE NEWSWIRE) — Zhibao Technology Inc. (“ZBAO” or the “Company”), a leading and high growth InsurTech […]
Canoo Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results
45% or $184.2 million Annual Adjusted EBITDA Improvement from $(408.6) million in 2022 to $(224.4) million in 2023 40% or […]
Australian Oilseeds Announces Ringing of the NASDAQ Closing Bell to Celebrate Milestone
Cootamundra New South Wales, April 01, 2024 (GLOBE NEWSWIRE) — Australian Oilseeds Holdings Limited (Nasdaq: COOT), a Cayman Islands exempted […]
Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410ST—a Modifier Gene Therapy—in GARDian Study for Stargardt Disease
Established Low Dose as Safe and Tolerable Dose in Current OCU410ST Clinical Trial DSMB Determination to Proceed with Medium Dose […]
Trump Media & Technology Group Files 10-K Report
SARASOTA, Fla., April 01, 2024 (GLOBE NEWSWIRE) — President Donald Trump created Truth Social to give the American people their […]
Ocugen to Host Conference Call on Tuesday, April 2 at 8:30 A.M. ET to Provide Business Update with Certain Financials for the Year Ending 2023
MALVERN, Pa., April 01, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused […]
